Fabrication of H-Mno2@pda Composite Nanocarriers for Enhancement of Anticancer Cell Performance by Photo-Chemical Synergetic Therapies

Zhang Xue-ya,Jiang Guo-hua,Song Gao,Liu Tian-qi,Sun Yan-fang,Zeng Zhi-yong

DOI: https://doi.org/10.1007/s11706-021-0553-9

2021-01-01

Frontiers of Materials Science

Abstract:The development of functional nanocarriers with multifunctional ability and expected degradability is of great significance for efficient drug delivery on tumor therapy. The release of non-specific drugs and serious side effects severely limit their therapeutic effectiveness, although chemotherapy has been far and widely used in clinical practice [1–4]. In the past few decades, nanosized drug carriers integrated with multi-responsive properties have emerged as promising candidates for anticancer treatment due to their long circulation in the bloodstream, high drug loading capacity, and “passive” targeting capability on account of the enhanced permeability and retention (EPR) effect [5–8]. MnO2 can react with H2O2, GSH and H + in the tumor microenvironment (TME) to generate Mn for tumor-specific imaging [9–11]. Meanwhile, Mn, as a Fenton-like reagent, can react with intracellular H2O2 to generate hydroxyl radical (•OH) through Fenton-like reactions [12–13]. In addition, they can alleviate tumor hypoxia by producing O2 and consuming GSH in the TME to greatly improve the ability of anti-cancer [14–15]. The h-MnO2 nanostructures can be used as nanocarriers to load the photosensitizer and chemotherapy drugs for the chemophotodynamic combination therapy [16–17]. Polydopamine (PDA), a FDA-approved polymer with good biodegradability and biocompatibility, has been widely used for the surface modification of nano-agents to facilitate the drug loading efficiency and enhance photothermal properties [18–21]. By the combination of abovementioned characteristics of h-MnO2 and PDA, there is a great need to manufacture novel nanocarriers for loading anticancer drugs. The photo-chemical synergistic therapy can achieve a more significant anti-tumor effect than that of traditional single chemotherapy at a lower drug dose, and can also reduce toxic side effects [22–23]. Herein, a nanocarrier consisting of h-MnO2 as the core and PDA as the shell was fabricated for the loading of doxorubicin (DOX). As expected, h-MnO2 can react with H2O2 in the TME conditions to produce O2 and reduce the consumption of reactive oxygen species (ROS) by GSH, which can decrease tumor hypoxia and improve the effectiveness of the anticancer treatment. Meanwhile, the rapid decomposition of MnO2 would result in the release of drug loaded and the production of Mn for the efficiency enhancement of the synergistic therapy. The obtained PDA coatings have strong light absorption in the near-infrared (NIR) range and simultaneously generate heat from the photothermal conversation and oxygen from the decomposition of H2O2 in TME to further improve the killing effect on cancer cells (Scheme 1). A schematic diagram for the synthesis of DOX/hMnO2@PDA nanoparticles (NPs) is shown in Scheme 1. SiO2 NPs were firstly synthesized by the hydrolysis of tetraethyl orthosilicate [24–26], and immediately used as a hard template. Next, MnO2 was onto solid SiO2 NPs in situ deposited, which was then etched to obtain h-MnO2 NPs [16]. h-MnO2 and DOX were further mixed and stirred for 12 h in the dark to prepare drug-loaded DOX/h-MnO2 NPs. 1 School of Materials Science and Engineering, Zhejiang Sci-Tech